Kynurenine potentiates the DOI head shake in mice

Kynurenine potentiates the DOI head shake in mice Kynurenine potentiates the DOI head shake in mice SAGE Publications, Inc.1995DOI: 10.1177/026988119500900112 Andrew C. McCreary Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, UK Sheila L. Handley Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, UK kynurenine DOI head shake mice case report Kynurenine is the first stable metabolite of the kynurenine pathway [which metabolises > 9007o of body tryptophan (Wolf, 1974) ]. A number of kynurenine pathway metabolites are known to have biological activity, including 3-hydroxykynurenine, xanthurenic acid, quinolinic acid and kynurenic acid (for reviews, see Schwarcz, 1993; Heyes, 1993; Stone and Connick, 1985). Recent studies have demonstrated that plasma kynurenine concentrations were elevated in all of seven patients suffering from Gilles de la Tourette's Syndrome (GTS), a disease characterised by motor and vocal tics (Dursun et al., 1994). It has been suggested that tic-like movements such as head shakes, which occur in rodents after a wide variety of pharmacological challenges, may model the tics observed in GTS (Handley and Dursun, 1992). In mice, systemic administration of kynurenine and its metabolite 3-hydroxykynurenine potentiated the head shakes induced by centrally administered 5-hydroxytryptamine (5-HT) or systemic L-5-hydroxytryptophan (5-HTP) (Handley and Miskin, 1977). 5-HT-related head shakes are thought to be http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Psychopharmacology SAGE

Kynurenine potentiates the DOI head shake in mice

Preview Only

Kynurenine potentiates the DOI head shake in mice

Abstract

Kynurenine potentiates the DOI head shake in mice SAGE Publications, Inc.1995DOI: 10.1177/026988119500900112 Andrew C. McCreary Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, UK Sheila L. Handley Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, UK kynurenine DOI head shake mice case report Kynurenine is the first stable metabolite of the kynurenine pathway [which metabolises > 9007o of body tryptophan (Wolf, 1974) ]. A number of kynurenine pathway metabolites are known to have biological activity, including 3-hydroxykynurenine, xanthurenic acid, quinolinic acid and kynurenic acid (for reviews, see Schwarcz, 1993; Heyes, 1993; Stone and Connick, 1985). Recent studies have demonstrated that plasma kynurenine concentrations were elevated in all of seven patients suffering from Gilles de la Tourette's Syndrome (GTS), a disease characterised by motor and vocal tics (Dursun et al., 1994). It has been suggested that tic-like movements such as head shakes, which occur in rodents after a wide variety of pharmacological challenges, may model the tics observed in GTS (Handley and Dursun, 1992). In mice, systemic administration of kynurenine and its metabolite 3-hydroxykynurenine potentiated the head shakes induced by centrally administered 5-hydroxytryptamine (5-HT) or systemic L-5-hydroxytryptophan (5-HTP) (Handley and Miskin, 1977). 5-HT-related head shakes are thought to be
Loading next page...
 
/lp/sage/kynurenine-potentiates-the-doi-head-shake-in-mice-VcC8uCOwXw
Publisher
Sage Publications
Copyright
Copyright © 1995 by SAGE Publications
ISSN
0269-8811
eISSN
0269-8811
D.O.I.
10.1177/026988119500900112
Publisher site
See Article on Publisher Site

Abstract

Kynurenine potentiates the DOI head shake in mice SAGE Publications, Inc.1995DOI: 10.1177/026988119500900112 Andrew C. McCreary Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, UK Sheila L. Handley Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, UK kynurenine DOI head shake mice case report Kynurenine is the first stable metabolite of the kynurenine pathway [which metabolises > 9007o of body tryptophan (Wolf, 1974) ]. A number of kynurenine pathway metabolites are known to have biological activity, including 3-hydroxykynurenine, xanthurenic acid, quinolinic acid and kynurenic acid (for reviews, see Schwarcz, 1993; Heyes, 1993; Stone and Connick, 1985). Recent studies have demonstrated that plasma kynurenine concentrations were elevated in all of seven patients suffering from Gilles de la Tourette's Syndrome (GTS), a disease characterised by motor and vocal tics (Dursun et al., 1994). It has been suggested that tic-like movements such as head shakes, which occur in rodents after a wide variety of pharmacological challenges, may model the tics observed in GTS (Handley and Dursun, 1992). In mice, systemic administration of kynurenine and its metabolite 3-hydroxykynurenine potentiated the head shakes induced by centrally administered 5-hydroxytryptamine (5-HT) or systemic L-5-hydroxytryptophan (5-HTP) (Handley and Miskin, 1977). 5-HT-related head shakes are thought to be

Journal

Journal of PsychopharmacologySAGE

Published: Jan 1, 1995

Keywords: kynurenine; DOI; head shake; mice; case report;

There are no references for this article.

Sorry, we don’t have permission to share this article on DeepDyve,
but here are related articles that you can start reading right now:

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off